Comorbidities, biomarkers and cause specific mortality in patients with irritable bowel syndrome: A phenome-wide association study.

Katharina Sophie SeelingLeonida HehlMara Sophie VellMiriam Daphne RendelKate Townsend CreasyChristian TrautweinDavid Marc Anton MehlerDaniel KeszthelyiKai Markus SchneiderCarolin Victoria Schneider

Published in: United European gastroenterology journal (2023)

Our large-scale association study determined IBS patients having an increased risk of several different comorbidities and that GlycA was increased in IBS patients.

Keyphrases

end stage renal disease
irritable bowel syndrome
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
cardiovascular disease
patient reported